Perelel, the five-year-old supplement brand, announced a $27 million round in funding, led by Prelude Growth Partners. Additional investors were Unilever Ventures, Willow Growth Partners and Selva Ventures, which previously participated in its Series A round in 2024.
Launched by Victoria Thain Gioia, Alex Taylor and obsetrician and gynecologist Dr. Banafsheh Bayati, Perelel was created to provide quality prenatal vitamins in a market where the product is recommended by doctors yet not regulated as drugs. The brand has since expanded into other categories like perimenopause, hormones and fertility.
The brand’s “doctor-founding coupled with its clinical validation and commitment to women’s health research” attracted Prelude to the investment, said Neda Daneshzadeh, co-founder and managing partner in a statement. The firm has invested in several beauty and wellness brands that have achieved exits, including Sol de Janeiro, Naturium and Phlur.
Learn more:
Beauty’s Great Menopause Conundrum
Over the past half decade, beauty has attempted to ride the menopause wave with mixed results. A new crop of brands is seeking success by embracing hormones, ageing Millennials and telemedicine.
